Loading…

POLATUZUMAB VEDOTIN + RITUXIMAB + LENALIDOMIDE IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL): PRIMARY ANALYSIS OF A PHASE 1B/2 TRIAL

Saved in:

Bibliographic Details
Published in:	Hematological oncology 2021-06, Vol.39 (S2)
Main Authors:	Diefenbach, C, Abrisqueta, P, Gonzalez-Barca, E, Panizo, C, Arguinano Perez, J. Maria, Miall, F, Bastos-Oreiro, M, Lopez-Guillermo, A, Banerjee, L, McMillan, A, Hirata, J, Musick, L, Saha, S, Croft, B, Seymour, E
Format:	Article
Language:	English
Subjects:	B-cell lymphoma Immunotherapy Lymphoma Monoclonal antibodies Rituximab Targeted cancer therapy
Citations:	Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!